377 related articles for article (PubMed ID: 20036101)
1. In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor.
Eefting D; de Vries MR; Grimbergen JM; Karper JC; van Bockel JH; Quax PH
J Vasc Surg; 2010 Feb; 51(2):429-37. PubMed ID: 20036101
[TBL] [Abstract][Full Text] [Related]
2. A novel urokinase receptor-targeted inhibitor for plasmin and matrix metalloproteinases suppresses vein graft disease.
Eefting D; Seghers L; Grimbergen JM; de Vries MR; de Boer HC; Lardenoye JW; Jukema JW; van Bockel JH; Quax PH
Cardiovasc Res; 2010 Nov; 88(2):367-75. PubMed ID: 20562095
[TBL] [Abstract][Full Text] [Related]
3. Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1.
Lamfers ML; Grimbergen JM; Aalders MC; Havenga MJ; de Vries MR; Huisman LG; van Hinsbergh VW; Quax PH
Circ Res; 2002 Nov; 91(10):945-52. PubMed ID: 12433840
[TBL] [Abstract][Full Text] [Related]
4. In vivo suppression of restenosis in balloon-injured rat carotid artery by adenovirus-mediated gene transfer of the cell surface-directed plasmin inhibitor ATF.BPTI.
Lamfers ML; Lardenoye JH; de Vries MR; Aalders MC; Engelse MA; Grimbergen JM; van Hinsbergh VW; Quax PH
Gene Ther; 2001 Apr; 8(7):534-41. PubMed ID: 11319620
[TBL] [Abstract][Full Text] [Related]
5. Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice.
Eefting D; Bot I; de Vries MR; Schepers A; van Bockel JH; Van Berkel TJ; Biessen EA; Quax PH
J Vasc Surg; 2009 Jul; 50(1):152-60. PubMed ID: 19563963
[TBL] [Abstract][Full Text] [Related]
6. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.
Berceli SA; Jiang Z; Klingman NV; Pfahnl CL; Abouhamze ZS; Frase CD; Schultz GS; Ozaki CK
J Vasc Surg; 2004 May; 39(5):1084-90. PubMed ID: 15111865
[TBL] [Abstract][Full Text] [Related]
7. Gene transfer of a broad spectrum CC-chemokine inhibitor reduces vein graft atherosclerosis in apolipoprotein E-knockout mice.
Ali ZA; Bursill CA; Hu Y; Choudhury RP; Xu Q; Greaves DR; Channon KM
Circulation; 2005 Aug; 112(9 Suppl):I235-41. PubMed ID: 16159823
[TBL] [Abstract][Full Text] [Related]
8. Short-term dexamethasone treatment inhibits vein graft thickening in hypercholesterolemic ApoE3Leiden transgenic mice.
Schepers A; Pires NM; Eefting D; de Vries MR; van Bockel JH; Quax PH
J Vasc Surg; 2006 Apr; 43(4):809-15. PubMed ID: 16616241
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of complement component C3 reduces vein graft atherosclerosis in apolipoprotein E3-Leiden transgenic mice.
Schepers A; de Vries MR; van Leuven CJ; Grimbergen JM; Holers VM; Daha MR; van Bockel JH; Quax PH
Circulation; 2006 Dec; 114(25):2831-8. PubMed ID: 17145993
[TBL] [Abstract][Full Text] [Related]
10. Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo.
Schepers A; Eefting D; Bonta PI; Grimbergen JM; de Vries MR; van Weel V; de Vries CJ; Egashira K; van Bockel JH; Quax PH
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2063-9. PubMed ID: 16825596
[TBL] [Abstract][Full Text] [Related]
11. Local gene transfer of tissue inhibitor of metalloproteinase-2 influences vein graft remodeling in a mouse model.
Hu Y; Baker AH; Zou Y; Newby AC; Xu Q
Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1275-80. PubMed ID: 11498453
[TBL] [Abstract][Full Text] [Related]
12. Topical HDL administration reduces vein graft atherosclerosis in apo E deficient mice.
Feng Y; Gordts SC; Chen F; Hu Y; Van Craeyveld E; Jacobs F; Carlier V; Feng Y; Zhang Z; Xu Q; Ni Y; De Geest B
Atherosclerosis; 2011 Feb; 214(2):271-8. PubMed ID: 20943224
[TBL] [Abstract][Full Text] [Related]
13. Pressure distention compared with pharmacologic relaxation in vein grafting upregulates matrix metalloproteinase-2 and -9.
Chung AW; Rauniyar P; Luo H; Hsiang YN; van Breemen C; Okon EB
J Vasc Surg; 2005 Oct; 42(4):747-56. PubMed ID: 16242564
[TBL] [Abstract][Full Text] [Related]
14. Cyclic adenosine monophosphate response-element binding protein activation by mitogen-activated protein kinase-activated protein kinase 3 and four-and-a-half LIM domains 5 plays a key role for vein graft intimal hyperplasia.
Nakanishi K; Saito Y; Azuma N; Sasajima T
J Vasc Surg; 2013 Jan; 57(1):182-93, 193.e1-10. PubMed ID: 23127979
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 4 is involved in human and mouse vein graft remodeling, and local gene silencing reduces vein graft disease in hypercholesterolemic APOE*3Leiden mice.
Karper JC; de Vries MR; van den Brand BT; Hoefer IE; Fischer JW; Jukema JW; Niessen HW; Quax PH
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1033-40. PubMed ID: 21330606
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound-mediated delivery of TIMP-3 plasmid DNA into saphenous vein leads to increased lumen size in a porcine interposition graft model.
Akowuah EF; Gray C; Lawrie A; Sheridan PJ; Su CH; Bettinger T; Brisken AF; Gunn J; Crossman DC; Francis SE; Baker AH; Newman CM
Gene Ther; 2005 Jul; 12(14):1154-7. PubMed ID: 15829995
[TBL] [Abstract][Full Text] [Related]
17. Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins.
George SJ; Baker AH; Angelini GD; Newby AC
Gene Ther; 1998 Nov; 5(11):1552-60. PubMed ID: 9930309
[TBL] [Abstract][Full Text] [Related]
18. Adenoviral gene transfer of a u-PA receptor-binding plasmin inhibitor and green fluorescent protein: inhibition of migration and visualization of expression.
Lamfers ML; Wijnberg MJ; Grimbergen JM; Huisman LG; Aalders MC; Cohen FN; Verheijen JH; van Hinsbergh VW; Quax PH
Thromb Haemost; 2000 Sep; 84(3):460-7. PubMed ID: 11019972
[TBL] [Abstract][Full Text] [Related]
19. Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure.
Miyachi H; Mii S; Enomoto A; Murakumo Y; Kato T; Asai N; Komori K; Takahashi M
J Vasc Surg; 2014 Aug; 60(2):479-489.e5. PubMed ID: 23948670
[TBL] [Abstract][Full Text] [Related]
20. Native atherosclerosis and vein graft arterialization: association with increased urokinase receptor expression in vitro and in vivo.
Okada SS; Golden MA; Raghunath PN; Tomaszewski JE; David ML; Kuo A; Kariko K; Barnathan ES
Thromb Haemost; 1998 Jul; 80(1):140-7. PubMed ID: 9684800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
